JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2021 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
AMENDMENT N°1 TO THE SHARE PURCHASE AGREEMENTShare Purchase Agreement • April 1st, 2021 • Bpifrance Participations SA • Oil & gas field machinery & equipment
JOINT FILING AGREEMENTJoint Filing Agreement • April 12th, 2018 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • January 25th, 2021 • Bpifrance Participations SA • Motor vehicles & passenger car bodies
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 8th, 2018 • Bpifrance Participations SA • Oil & gas field exploration services
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • May 30th, 2017 • Bpifrance Participations SA • Oil & gas field machinery & equipment
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2016 • Bpifrance Participations SA • Telephone communications (no radiotelephone)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the ordinary shares of Orange S.A. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 16, 2016.
SHAREHOLDERS AGREEMENT CGG VERITASShareholders Agreement • May 30th, 2017 • Bpifrance Participations SA • Oil & gas field exploration services
For any decision submitted to the vote of the shareholders general meeting, the Parties shall exchange their respective opinions on the proposed decisions and try to reach a common position on this decision, although reaching a common position is not mandatory.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2021 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2021 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
AMENDMENT N°1 TO RELATIONSHIP AGREEMENTRelationship Agreement • May 11th, 2021 • Bpifrance Participations SA • Services-engineering services
SHARE PURCHASE AGREEMENTShare Purchase Agreement • January 11th, 2022 • Bpifrance Participations SA • Services-engineering services
THIS SHARE PURCHASE AGREEMENT (this “Agreement”) is made as of January 9, 2022 (the “Execution Date”) by and between TechnipFMC plc, a public limited company formed under the laws of England and Wales (“Seller”), and Bpifrance Participations S.A., a société anonyme incorporated under the laws of France (“Purchaser”). Seller and Purchaser are each referred to herein individually as a “Party” and collectively as the “Parties”.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Bpifrance Participations SA • Services-prepackaged software
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the ordinary shares of Talend S.A. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 14, 2017.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2018 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the common stock of Adverum Biotechnologies, Inc. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 12, 2018.
JOINT FILING AGREEMENTJoint Filing Agreement • November 16th, 2022 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 15th, 2018 • Bpifrance Participations SA • Services-prepackaged software
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the ordinary shares of Talend S.A. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 15, 2018.
JOINT FILING AGREEMENTJoint Filing Agreement • June 30th, 2023 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the ordinary shares of Cellectis S.A. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 14, 2017.
JOINT FILING AGREEMENTJoint Filing Agreement • April 23rd, 2021 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2017 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the ordinary shares of DBV Technologies S.A. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 14, 2017.
JOINT FILING AGREEMENTJoint Filing Agreement • May 30th, 2017 • Bpifrance Participations SA • Oil & gas field exploration services
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • February 12th, 2018 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the ordinary shares of DBV Technologies S.A. and further agree that this Joint Filing Agreement shall be included as an Exhibit to such joint filing. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of February 12, 2018.
JOINT FILING AGREEMENTJoint Filing Agreement • August 4th, 2020 • Bpifrance Participations SA • Biological products, (no disgnostic substances)
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
JOINT FILING AGREEMENTJoint Filing Agreement • December 13th, 2018 • Bpifrance Participations SA • Pharmaceutical preparations
This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument.
